Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2026-01-01 @ 1:19 PM
Study NCT ID:
NCT04812535
Status:
TERMINATED
Last Update Posted:
2025-02-11
First Post:
2021-03-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.
Sponsor:
InflaRx GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IFX-1 P2.8
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |